Terpenes: The Other Half of Quality

Two growers, same THC number on the lab report. One jar smells like cut grass and the other like lemon peel and diesel. People will pay double for the second one and tell you it “hits different.” They’re not imagining it — but most of what they think is happening isn’t. This lesson is about the half of quality that the THC percentage never captures, and about being honest where the science still is.

What You Need to Know

Terpenes come from their own family of enzymes

In Lesson 1 you saw cannabinoids branch from one mother molecule. Terpenes work on a parallel logic, with their own gene family. Allen and colleagues sequenced the lot: 55 terpene synthase genes in Cannabis sativa — the most complete catalogue to date, well up on the 33 found in earlier work. They sort into three subfamilies:

• TPS-b — monoterpene synthases (the lighter, C10 terpenes: myrcene, pinene, limonene).
• TPS-a — sesquiterpene synthases (the heavier, C15 terpenes: caryophyllene, humulene).
• TPS-c — diterpene synthases (a minor group).

Which of those 55 genes a given plant switches on — and how hard — decides the smell. In Purple Kush, three genes (TPS1, TPS18, TPS5) dominate the output, but 16 genes each contribute at least 1% of the total. Different cultivar, different subset firing, different aroma.

Seb’s Corner. The smell of your plant is a gene-expression fingerprint. It is not magic, not “the soil,” not the full moon. When two phenotypes from the same pack smell different, you’re seeing different terpene synthase genes expressing at different strengths. That’s also why selecting for smell in a breeding programme works — you’re selecting which of those 55 genes you carry forward.

Two pathways feed the terpenes

Both papers confirm the dual-pathway system. The plant builds terpene precursors two ways:

• The MEP pathway, in the plastids, makes GPP (C10) → monoterpenes.
• The MEV pathway, in the cytosol, makes FPP (C15) → sesquiterpenes.

You don’t act on these directly. But knowing there are two separate supply lines explains why a plant can be heavy in monoterpenes and light in sesquiterpenes, or the reverse — they’re built in different compartments from different feedstock.

A genuinely strange fact: roots make terpenes too

Allen’s team found 10 monoterpene synthase genes that are highly root-specific — 6 of them express only in roots. Most growers think of terpenes as a flower thing. They’re not. The roots run their own distinct monoterpene programme, probably for soil defence and microbial signalling. It doesn’t change your harvest, but it should change how you think: the plant is a whole system, not a bud on a stick.

The big five aren’t the whole story

Everyone names myrcene, limonene, pinene, linalool, caryophyllene. Chacon and colleagues catalogue the secondary terpenes — bisabolol, guaiol, nerolidol, geraniol, fenchol and more — present at tiny amounts (typically under 0.1% by mass, versus 0.5–3% for the primaries) but biologically active. The honest catch: most labs don’t even report them, because reference standards don’t exist for many. So the “full profile” of most cultivars is genuinely unknown.

Seb’s Corner. When a menu lists a strain’s “terpene profile,” it’s listing the handful the lab had standards for. The minor terpenes — the ones doing some of the most interesting chemistry — are usually invisible on the report. Absence on a COA is not absence in the jar.

The entourage effect, audited

Here’s where Dave keeps it honest. The “entourage effect” is the claim that cannabinoids and terpenes work together to shape the experience. Chacon’s review is even-handed: some evidence supports it, some refutes it. A few terpenes do appear to modulate CB1/CB2 receptor activity; others act on entirely separate targets. There’s also a real biochemical link — high-CBGA chemotypes correlate with elevated bisabolol, guaiol, and eudesmol, suggesting the cannabinoid and terpene pathways share regulatory wiring.

But “it’s real chemistry” is not the same as “we’ve proven the effect a marketer is selling you.” The current state, said plainly: it’s mixed, emerging, and nowhere near settled. We do not make claims about what any of this does in a person — that’s a hard rule and it’s also just intellectually honest. What we can say: the terpene profile is real, it’s heritable, and it’s a legitimate quality axis. The rest is “promising, unproven,” and anyone telling you otherwise is ahead of the data.

How To Apply This

• Grow terpene-first as well as yield-first. Smell is a quality driver buyers reward. Select phenotypes by aroma, not just by trichome count, and you’re selecting gene expression you can carry forward.
• Protect terpenes in handling. They’re volatile. Heat, light, rough handling and over-drying drive them off — the same enemies as Lesson 1’s THCA, for the same reason. A cool, slow, dark cure preserves the aroma you grew.
• Pick genetics for the profile you want. If you want a citrus or fuel nose, that’s a TPS-b/TPS-a expression pattern set by the genetics. Buy for it.
• Read a COA for what it omits. Treat the listed terpenes as a partial picture. Don’t assume a strain is “flat” because the lab only reported three.

Watch Out For

• Entourage claims dressed as fact. “These terpenes enhance the effect” is a hypothesis with mixed support, not a settled result. Note the uncertainty; never make a medical claim.
• Chasing terpenes with bottles. No additive reliably “increases terpenes.” Like cannabinoids, the ceiling is genetic; your job is to reach it through plant health and clean handling, not to exceed it.
• Confusing strong smell with strong effect. Aroma intensity and cannabinoid content are separate axes. A pungent plant isn’t automatically more potent.
• Trusting menu terpene percentages as complete. Secondary terpenes are routinely unmeasured.

Quiz

1. How many terpene synthase genes did Allen et al. identify, and what determines a cultivar’s smell?
2. Name the two precursor pathways and which class of terpene each feeds.
3. What surprising tissue, besides flowers, runs its own distinct monoterpene programme?
4. Why are many “secondary” terpenes missing from lab reports?
5. State the honest current status of the entourage effect in one sentence.

Answer key.

1. 55 genes. Which subset of those genes the plant expresses — and how strongly — determines the aroma.
2. MEP pathway (plastids) → GPP → monoterpenes; MEV pathway (cytosol) → FPP → sesquiterpenes.
3. The roots — 10 root-specific monoterpene synthase genes, 6 expressing only in roots.
4. Reference standards don’t exist for many of them, so labs can’t quantify them; they’re real but unmeasured.
5. The chemistry is real and the pathways are linked, but the evidence for a defined synergistic effect is mixed and unproven — promising, not settled.

Sources

Allen, K. D., et al. (2019). Genomic characterization of the complete terpene synthase gene family from Cannabis sativa. PLOS ONE, 14(9), e0222363. https://doi.org/10.1371/journal.pone.0222363. CC-BY 4.0.

Chacon, F. T., Raup-Konsavage, W. M., Vrana, K. E., & Kellogg, J. J. (2022). Secondary terpenes in Cannabis sativa L.: Synthesis and synergy. Biomedicines, 10(12), 3142. https://doi.org/10.3390/biomedicines10123142. CC-BY 4.0.

Next: Lesson 3 — Spectrum engineering, and the far-red and UV reality check.